Brexanolone (Zulresso) gained FDA approval this week as the first postpartum depression drug. (MedPage Today)
In other news, childbirth complications could set kids up for social anxiety in their teen years. (Infant and Child Development)
The fast-acting psychedelic 5-MeO-DMT, found in some toad species (and fostering the risky practice of toad-licking), improved anxiety and depression symptoms in around 80% of those responding to an online survey. (The American Journal of Drug and Alcohol Abuse)
First hospitalized with what doctors thought was schizophrenia-induced psychosis and placed on aripiprazole, a 14-year old boy actually turned out to be infected with bacteria from a cat scratch. (Journal of Central Nervous System Disease)
Inflammation may be one of the underlying links between depression and coronary heart disease. (Molecular Psychiatry)
Adding samidorphan to olanzapine for schizophrenia helped curb the amount of weight gain related to olanzapine with similar efficacy and tolerability. (The American Journal of Psychiatry)
Are autism studies leaving girls out? (The Atlantic)
Instagram is a breeding ground for content promoting eating disorders, according to a BBC investigation.
Source: MedicalNewsToday.com
